Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Disturbances in Heart Rhythm01:29

Disturbances in Heart Rhythm

Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sympathetic Overdrive and Role of Beta-blockers in Various Forms of Heart Failure: A Consensus Statement from India.

The Journal of the Association of Physicians of India·2024
Same author

Indian Consensus on the Role and Position of Angiotensin Receptor-neprilysin Inhibitors in the Management of Heart Failure.

The Journal of the Association of Physicians of India·2024
Same author

Consensus Statement from India on the Renal Benefits of ARNi, SGLT-2i, and Bisoprolol in Chronic Kidney Disease.

The Journal of the Association of Physicians of India·2024
Same author

Role of Bisoprolol in Heart Failure Management: A Consensus Statement from India.

The Journal of the Association of Physicians of India·2024
Same author

Current Place of SGLT2i in the Management of Heart Failure: An Expert Opinion from India.

The Journal of the Association of Physicians of India·2024
Same author

The Promise of Cilnidipine in Hypertension with Comorbidities: National Consensus Statement: National Consensus Group Comprises Cardiologists, Nephrologists, and Diabetologists from India in a National Meet at New Delhi held on 22<sup>nd</sup> May 2022.

The Journal of the Association of Physicians of India·2024

Related Experiment Video

Updated: Jul 1, 2026

Intracoronary Acetylcholine Provocation Testing for Assessment of Coronary Vasomotor Disorders
06:39

Intracoronary Acetylcholine Provocation Testing for Assessment of Coronary Vasomotor Disorders

Published on: August 18, 2016

DC cardioversion and coronary artery spasm.

S B Siwach, V K Katyal

    The Journal of the Association of Physicians of India
    |August 1, 1989
    PubMed
    Summary

    Direct current shock for atrial fibrillation can cause ST segment elevation due to coronary artery spasm. This rare complication highlights potential risks associated with electrical cardioversion.

    Area of Science:

    • Cardiology
    • Electrophysiology
    • Medical Complications

    Background:

    • Atrial fibrillation is a common cardiac arrhythmia requiring treatment.
    • Electrical cardioversion using direct current (DC) shock is a standard treatment for atrial fibrillation.
    • ST segment elevation on electrocardiogram (ECG) typically indicates myocardial ischemia or infarction.

    Observation:

    • A 55-year-old male patient experienced significant ST segment elevation on ECG after undergoing DC shock for lone atrial fibrillation.
    • The ST segment elevation was transient and not associated with other signs of acute coronary syndrome.

    Findings:

    • The observed ST segment elevation following DC shock is hypothesized to be caused by coronary artery spasm.
    • This suggests a potential, albeit rare, complication of direct current electrical stimulation on coronary arteries.

    More Related Videos

    Standardized Model of Ventricular Fibrillation and Advanced Cardiac Life Support in Swine
    05:36

    Standardized Model of Ventricular Fibrillation and Advanced Cardiac Life Support in Swine

    Published on: January 30, 2020

    Measurement of Myocardial Lactate Production for Diagnosis of Coronary Microvascular Spasm
    06:18

    Measurement of Myocardial Lactate Production for Diagnosis of Coronary Microvascular Spasm

    Published on: September 17, 2021

    Related Experiment Videos

    Last Updated: Jul 1, 2026

    Intracoronary Acetylcholine Provocation Testing for Assessment of Coronary Vasomotor Disorders
    06:39

    Intracoronary Acetylcholine Provocation Testing for Assessment of Coronary Vasomotor Disorders

    Published on: August 18, 2016

    Standardized Model of Ventricular Fibrillation and Advanced Cardiac Life Support in Swine
    05:36

    Standardized Model of Ventricular Fibrillation and Advanced Cardiac Life Support in Swine

    Published on: January 30, 2020

    Measurement of Myocardial Lactate Production for Diagnosis of Coronary Microvascular Spasm
    06:18

    Measurement of Myocardial Lactate Production for Diagnosis of Coronary Microvascular Spasm

    Published on: September 17, 2021

  • The mechanism may involve direct electrical effects or autonomic nervous system responses triggered by the shock.
  • Implications:

    • Clinicians should be aware of this potential complication during and after electrical cardioversion.
    • Distinguishing this artifact from true ischemic events is crucial for appropriate patient management.
    • Further research may elucidate the precise mechanism and incidence of DC shock-induced coronary artery spasm.